Search VMD
VIEMED HEALTHCARE, INC.
Nasdaq · CIK 1729149
Last close9.13
Daily change+0.05 (0.55%)
10 Years gain+30.06%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
VMD · STANDARD
SIC 8090 · Services-Misc Health & Allied Services, NEC · Fiscal year end 1231
Fundamental
59.2Momentum
49.5Acceleration
49.5Confidence
79.0Annual Revenue8
Quarterly Revenue33
Annual CFO8
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.1 / 25
Quality13.4 / 25
Capital Efficiency7.1 / 20
Balance Sheet11.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators4.3 / 5
Signals
Share count reductionDiluted share count declined 1.2063%.
Warnings
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM29.54%OK
Revenue CAGR 3Y24.87%OK
Gross Margin57.53%OK
Operating Margin6.76%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC9.96%OK
Incremental Operating Margin 3Y8.62%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-1.21%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $270.28M | $155.46M | $22.95M | $51.92M | $11.93M | 57.52% | 8.49% | 4.41% | 12.55% | 40.82M |
| 2025 FY Dec 31, 2024 | $224.26M | $133.20M | $17.90M | $39.09M | $1.32M | 59.4% | 7.98% | 0.59% | 11.18% | 40.81M |
| 2025 FY Dec 31, 2023 | $183.01M | $112.78M | $14.33M | $45.21M | $19.12M | 61.63% | 7.83% | 10.45% | 10.83% | 40.38M |
| 2024 FY Dec 31, 2022 | $138.83M | $84.68M | $8.25M | $27.75M | $4.85M | 60.99% | 5.94% | 3.49% | 7.5% | 39.81M |
| 2022 FY Dec 31, 2021 | $117.06M | $73.41M | $11.58M | $22.49M | $2.75M | 62.71% | 9.89% | 2.35% | 12.95% | 40.68M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $288.48M | sum latest 4 fiscal quarters Revenue | OK | 0001729149-26-000042, 0001729149-25-000149 |
| Revenue Growth TTM | 29.54% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001729149-26-000042, 0001729149-25-000149 |
| Revenue CAGR 3Y | 24.87% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001729149-26-000009 |
| Revenue CAGR 5Y | 15.53% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001729149-26-000009 |
| Gross Profit CAGR 3Y | 22.45% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001729149-26-000009 |
| Operating Income Growth | 27.5% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001729149-26-000042, 0001729149-25-000149 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 57.53% | Gross Profit / Revenue | OK | 0001729149-26-000042, 0001729149-25-000149 |
| Operating Margin | 6.76% | Operating Income / Revenue | OK | 0001729149-26-000042, 0001729149-25-000149 |
| ROIC | 9.96% | NOPAT / Average Invested Capital | OK | 0001729149-26-000042, 0001729149-25-000149 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001729149-26-000042 |
| Current Ratio | 1.13x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 1.51x | (Cash + Short-term Investments) / Total Debt | OK | 0001729149-26-000042 |
| Revenue per Diluted Share | $7.01 | Revenue / Diluted Shares | OK | 0001729149-26-000042, 0001729149-25-000149 |